268 related articles for article (PubMed ID: 23921126)
1. Transcription factor ATF3 links host adaptive response to breast cancer metastasis.
Wolford CC; McConoughey SJ; Jalgaonkar SP; Leon M; Merchant AS; Dominick JL; Yin X; Chang Y; Zmuda EJ; O'Toole SA; Millar EK; Roller SL; Shapiro CL; Ostrowski MC; Sutherland RL; Hai T
J Clin Invest; 2013 Jul; 123(7):2893-906. PubMed ID: 23921126
[TBL] [Abstract][Full Text] [Related]
2. Stress-Inducible Gene
Middleton JD; Fehlman J; Sivakumar S; Stover DG; Hai T
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298975
[TBL] [Abstract][Full Text] [Related]
3. Stress-inducible gene
Chang YS; Jalgaonkar SP; Middleton JD; Hai T
Proc Natl Acad Sci U S A; 2017 Aug; 114(34):E7159-E7168. PubMed ID: 28784776
[TBL] [Abstract][Full Text] [Related]
4. ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton.
Yuan X; Yu L; Li J; Xie G; Rong T; Zhang L; Chen J; Meng Q; Irving AT; Wang D; Williams ED; Liu JP; Sadler AJ; Williams BR; Shen L; Xu D
Cancer Res; 2013 Jun; 73(12):3625-37. PubMed ID: 23536558
[TBL] [Abstract][Full Text] [Related]
5. Activating transcription factor 3 (ATF3) protects against lipopolysaccharide-induced acute lung injury via inhibiting the expression of TL1A.
Qian L; Zhao Y; Guo L; Li S; Wu X
J Cell Physiol; 2017 Dec; 232(12):3727-3734. PubMed ID: 28177121
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis.
Waight JD; Netherby C; Hensen ML; Miller A; Hu Q; Liu S; Bogner PN; Farren MR; Lee KP; Liu K; Abrams SI
J Clin Invest; 2013 Oct; 123(10):4464-78. PubMed ID: 24091328
[TBL] [Abstract][Full Text] [Related]
7. A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development.
Yin X; Dewille JW; Hai T
Oncogene; 2008 Apr; 27(15):2118-27. PubMed ID: 17952119
[TBL] [Abstract][Full Text] [Related]
8. POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages.
Seoane S; Martinez-Ordoñez A; Eiro N; Cabezas-Sainz P; Garcia-Caballero L; Gonzalez LO; Macia M; Sanchez L; Vizoso F; Perez-Fernandez R
J Pathol; 2019 Nov; 249(3):381-394. PubMed ID: 31292963
[TBL] [Abstract][Full Text] [Related]
9. Adenylate kinase-4 is a marker of poor clinical outcomes that promotes metastasis of lung cancer by downregulating the transcription factor ATF3.
Jan YH; Tsai HY; Yang CJ; Huang MS; Yang YF; Lai TC; Lee CH; Jeng YM; Huang CY; Su JL; Chuang YJ; Hsiao M
Cancer Res; 2012 Oct; 72(19):5119-29. PubMed ID: 23002211
[TBL] [Abstract][Full Text] [Related]
10. ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells.
Yin X; Wolford CC; Chang YS; McConoughey SJ; Ramsey SA; Aderem A; Hai T
J Cell Sci; 2010 Oct; 123(Pt 20):3558-65. PubMed ID: 20930144
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of TLR-signaling pathways by activating transcription factor-3.
Whitmore MM; Iparraguirre A; Kubelka L; Weninger W; Hai T; Williams BR
J Immunol; 2007 Sep; 179(6):3622-30. PubMed ID: 17785797
[TBL] [Abstract][Full Text] [Related]
12. A specific gene expression signature for visceral organ metastasis in breast cancer.
Savci-Heijink CD; Halfwerk H; Koster J; Horlings HM; van de Vijver MJ
BMC Cancer; 2019 Apr; 19(1):333. PubMed ID: 30961553
[TBL] [Abstract][Full Text] [Related]
13. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4.
Gilchrist M; Thorsson V; Li B; Rust AG; Korb M; Roach JC; Kennedy K; Hai T; Bolouri H; Aderem A
Nature; 2006 May; 441(7090):173-8. PubMed ID: 16688168
[TBL] [Abstract][Full Text] [Related]
14. Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model.
Wang Z; Xu D; Ding HF; Kim J; Zhang J; Hai T; Yan C
Oncogene; 2015 Sep; 34(38):4975-84. PubMed ID: 25531328
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II facilitates breast cancer cell migration and metastasis.
Rodrigues-Ferreira S; Abdelkarim M; Dillenburg-Pilla P; Luissint AC; di-Tommaso A; Deshayes F; Pontes CL; Molina A; Cagnard N; Letourneur F; Morel M; Reis RI; Casarini DE; Terris B; Couraud PO; Costa-Neto CM; Di Benedetto M; Nahmias C
PLoS One; 2012; 7(4):e35667. PubMed ID: 22536420
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor ATF3 mediates the radioresistance of breast cancer.
Zhao W; Sun M; Li S; Chen Z; Geng D
J Cell Mol Med; 2018 Oct; 22(10):4664-4675. PubMed ID: 30117642
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.
Schwab LP; Peacock DL; Majumdar D; Ingels JF; Jensen LC; Smith KD; Cushing RC; Seagroves TN
Breast Cancer Res; 2012 Jan; 14(1):R6. PubMed ID: 22225988
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin-induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal.
Niknejad N; Gorn-Hondermann I; Ma L; Zahr S; Johnson-Obeseki S; Corsten M; Dimitroulakos J
Int J Cancer; 2014 Jan; 134(2):268-79. PubMed ID: 23824972
[TBL] [Abstract][Full Text] [Related]
19. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
[TBL] [Abstract][Full Text] [Related]
20. ATF3 Is a Key Regulator of Macrophage IFN Responses.
Labzin LI; Schmidt SV; Masters SL; Beyer M; Krebs W; Klee K; Stahl R; Lütjohann D; Schultze JL; Latz E; De Nardo D
J Immunol; 2015 Nov; 195(9):4446-55. PubMed ID: 26416280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
